A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Nigerians have begun scrambling for Lenacapavir, a newly introduced injection for the prevention of Human Immunodeficiency ...

HIV activist Rathabeng Mamabolo highlights the alarming trend of men relying on partners for HIV testing, urging a shift towards personal responsibility in health management.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

With the patent for Semaglutide expiring on March 20, a number of Indian generic drug manufacturers are expected to enter the ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune ...